VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,104,732 | +162.1% | 255,725 | +348.3% | 0.00% | +50.0% |
Q4 2022 | $421,540 | -33.1% | 57,042 | -1.4% | 0.00% | -60.0% |
Q2 2022 | $630,000 | -36.7% | 57,842 | -34.3% | 0.01% | -37.5% |
Q1 2022 | $996,000 | -21.4% | 88,076 | +9.0% | 0.01% | -20.0% |
Q4 2021 | $1,267,000 | +29.8% | 80,779 | +24.3% | 0.01% | -33.3% |
Q1 2021 | $976,000 | +356.1% | 64,980 | +298.1% | 0.02% | +400.0% |
Q4 2020 | $214,000 | +41.7% | 16,324 | +4.3% | 0.00% | +50.0% |
Q3 2020 | $151,000 | -23.7% | 15,654 | +30.1% | 0.00% | -66.7% |
Q4 2019 | $198,000 | – | 12,036 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |